D-1084-2019 Class III Terminated
FDA drug recall D-1084-2019 was initiated by X-Gen Pharmaceuticals Inc. on Mar 29, 2019 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine… The recall status is terminated (terminated Jun 2, 2021). Affected quantity: 24,966 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 17, 2019
- Initiation Date
- Mar 29, 2019
- Termination Date
- Jun 2, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,966 vials
Product description
Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.
Reason for recall
Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.
Distribution pattern
Nationwide in the USA.
Code information
Lots #: PMXA1917, Exp 09/2020; PMXA1937, PMXA1938, Exp 11/2020;
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1084-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026